Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s share price rose 1% on Thursday . The stock traded as high as $50.50 and last traded at $50.50. Approximately 2,107 shares were traded during mid-day trading, an increase of 85% from the average daily volume of 1,136 shares. The stock had previously closed at $50.00.
Hikma Pharmaceuticals Price Performance
The business’s 50-day simple moving average is $49.11 and its 200-day simple moving average is $50.02.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- What Are Growth Stocks and Investing in Them
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What is the Hang Seng index?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
